- Home
- RELI vs TTNP Comparison
RELI vs TTNP Comparison
Compare RELI & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELI
- TTNP
- Stock Information
- Founded
- RELI 2013
- TTNP 1991
- Country
- RELI United States
- TTNP United States
- Employees
- RELI N/A
- TTNP N/A
- Industry
- RELI Specialty Insurers
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RELI Finance
- TTNP Health Care
- Exchange
- RELI Nasdaq
- TTNP Nasdaq
- Market Cap
- RELI 3.4M
- TTNP 3.4M
- IPO Year
- RELI N/A
- TTNP 1996
- Fundamental
- Price
- RELI $1.24
- TTNP $4.00
- Analyst Decision
- RELI Strong Buy
- TTNP
- Analyst Count
- RELI 1
- TTNP 0
- Target Price
- RELI $119.00
- TTNP N/A
- AVG Volume (30 Days)
- RELI 31.3K
- TTNP 33.6K
- Earning Date
- RELI 03-06-2025
- TTNP 05-14-2025
- Dividend Yield
- RELI N/A
- TTNP N/A
- EPS Growth
- RELI N/A
- TTNP N/A
- EPS
- RELI N/A
- TTNP N/A
- Revenue
- RELI $14,054,361.00
- TTNP N/A
- Revenue This Year
- RELI N/A
- TTNP N/A
- Revenue Next Year
- RELI N/A
- TTNP N/A
- P/E Ratio
- RELI N/A
- TTNP N/A
- Revenue Growth
- RELI 2.35
- TTNP N/A
- 52 Week Low
- RELI $1.13
- TTNP $3.03
- 52 Week High
- RELI $18.53
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- RELI 36.10
- TTNP 55.27
- Support Level
- RELI $1.13
- TTNP $3.48
- Resistance Level
- RELI $1.37
- TTNP $4.47
- Average True Range (ATR)
- RELI 0.07
- TTNP 0.35
- MACD
- RELI 0.01
- TTNP 0.01
- Stochastic Oscillator
- RELI 40.74
- TTNP 56.07
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.